Michael K Ong1, Stanton A Glantz. 1. Division of General Internal Medicine, Department of Medicine, University of California, San Francisco 94143-1390, USA.
Abstract
PURPOSE: Smoking is the leading controllable risk factor for heart disease. Only about 69% of U.S. indoor workers are currently covered by a smoke-free workplace policy. This analysis projects the cardiovascular health and economic effects of making all U.S. workplaces smoke free after 1 year and at steady state. METHODS: We estimated the number of U.S. indoor workers not covered by smoke-free workplace policies, and the effects of making all workplaces smoke free on smoking behavior and on the relative risks of acute myocardial infarctions and strokes. One-year and steady-state results were calculated using an exponential decline model. A Monte Carlo simulation was performed for a sensitivity analysis. RESULTS: The first-year effect of making all workplaces smoke free would produce about 1.3 million new quitters and prevent over 950 million cigarette packs from being smoked annually, worth about 2.3 billion dollars in pretax sales to the tobacco industry. In 1 year, making all workplaces smoke free would prevent about 1500 myocardial infarctions and 350 strokes, and result in nearly $60 [corrected] in savings in direct medical costs. At steady state, 6250 myocardial infarctions and 1270 strokes would be prevented, and $279 million [corrected] would be saved in direct medical costs annually. Reductions in passive smoking would account for 60% of effects among acute myocardial infarctions. CONCLUSION: Making all U.S. workplaces smoke free would result in considerable health and economic benefits within 1 year. Reductions in passive smoking would account for a majority of these savings. Similar effects would occur with enactment of state or local smoke-free policies.
PURPOSE: Smoking is the leading controllable risk factor for heart disease. Only about 69% of U.S. indoor workers are currently covered by a smoke-free workplace policy. This analysis projects the cardiovascular health and economic effects of making all U.S. workplaces smoke free after 1 year and at steady state. METHODS: We estimated the number of U.S. indoor workers not covered by smoke-free workplace policies, and the effects of making all workplaces smoke free on smoking behavior and on the relative risks of acute myocardial infarctions and strokes. One-year and steady-state results were calculated using an exponential decline model. A Monte Carlo simulation was performed for a sensitivity analysis. RESULTS: The first-year effect of making all workplaces smoke free would produce about 1.3 million new quitters and prevent over 950 million cigarette packs from being smoked annually, worth about 2.3 billion dollars in pretax sales to the tobacco industry. In 1 year, making all workplaces smoke free would prevent about 1500 myocardial infarctions and 350 strokes, and result in nearly $60 [corrected] in savings in direct medical costs. At steady state, 6250 myocardial infarctions and 1270 strokes would be prevented, and $279 million [corrected] would be saved in direct medical costs annually. Reductions in passive smoking would account for 60% of effects among acute myocardial infarctions. CONCLUSION: Making all U.S. workplaces smoke free would result in considerable health and economic benefits within 1 year. Reductions in passive smoking would account for a majority of these savings. Similar effects would occur with enactment of state or local smoke-free policies.
Authors: Carla J Berg; Christine Makosky Daley; Niaman Nazir; Angel Cully; Christina M Pacheco; Taneisha Buchanan; Jasjit S Ahluwalia; K Allen Greiner; Won S Choi Journal: J Health Dispar Res Pract Date: 2012
Authors: Carla J Berg; Christine M Daley; Niaman Nazir; Angel Cully; Christina M Pacheco; Taneisha Buchanan; Jasjit S Ahuwalia; K Allen Greiner; Won S Choi Journal: J Health Dispar Res Pract Date: 2012-01-01
Authors: Yuan-Chin Amy Lee; Manuela Marron; Simone Benhamou; Christine Bouchardy; Wolfgang Ahrens; Hermann Pohlabeln; Pagona Lagiou; Dimitrios Trichopoulos; Antonio Agudo; Xavier Castellsague; Vladimir Bencko; Ivana Holcatova; Kristina Kjaerheim; Franco Merletti; Lorenzo Richiardi; Gary J Macfarlane; Tatiana V Macfarlane; Renato Talamini; Luigi Barzan; Cristina Canova; Lorenzo Simonato; David I Conway; Patricia A McKinney; Raymond J Lowry; Linda Sneddon; Ariana Znaor; Claire M Healy; Bernard E McCartan; Paul Brennan; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Yuan-Chin Amy Lee; Paolo Boffetta; Erich M Sturgis; Qingyi Wei; Zuo-Feng Zhang; Joshua Muscat; Philip Lazarus; Elena Matos; Richard B Hayes; Deborah M Winn; David Zaridze; Victor Wünsch-Filho; Jose Eluf-Neto; Sergio Koifman; Dana Mates; Maria Paula Curado; Ana Menezes; Leticia Fernandez; Alexander W Daudt; Neonila Szeszenia-Dabrowska; Eleonora Fabianova; Peter Rudnai; Gilles Ferro; Julien Berthiller; Paul Brennan; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-08 Impact factor: 4.254
Authors: John D Prochaska; James N Burdine; Kendra Bigsby; Marcia G Ory; Joseph R Sharkey; Kenneth R McLeroy; Nelda Mier; Brian Colwell Journal: Prev Chronic Dis Date: 2008-12-15 Impact factor: 2.830